What is the main business of Excelya Poland?

The main business activity of Excelya Poland focuses on other research and experimental development on natural sciences and engineering.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 24, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Jana Z Kolna 11, 80-864 Gdańsk.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of $14,378 in 2025, which is a decrease of 73.7% compared to 2024.

Is the company profitable?

No, in 2025 the company was not profitable, reporting a net loss of $172,103. For comparison, in 2024 the loss was $160,304, meaning the company increased its loss by 7.1%.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $91,578 in 2025, representing 51% of all operating expenses.

Excelya Polandsp. z o.o.

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-03-24

Share capital

5,000.00 PLN

Activity description

Excelya Poland provides contract research organization (CRO) services to biotechnology, pharmaceutical, and medical device companies. It supports the clinical development lifecycle with clinical operations, pharmacovigilance, data management, regulatory support, and FSP and resourcing services.

Registered address

ul. Jana Z Kolna 11, 80-864 Gdańsk, Poland

Website

excelya.com

Social media

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 15 days early.

202511/06/2026
202410/07/2025
202305/07/2024
202206/07/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Other research and experimental development on natural sciences and engineering1,106 / 1,565

Top 71%

Division · Scientific research and development1,351 / 1,953

Top 69%

Sector · Professional, scientific and technical activities30,871 / 39,211

Top 79%

City · Gdańsk6,323 / 7,552

Top 84%

Voivodeship · Pomorskie17,282 / 20,152

Top 86%

Country · Poland254,573 / 297,932

Top 85%

Results vs industry

Revenue

This companyUSD 14.38kMedianUSD 73.26kAverageUSD 3.23m

Net profit

This companyUSD -172.10kMedianUSD 69.70AverageUSD 82.18k

Operating costs

This companyUSD 178.48kMedianUSD 75.78kAverageUSD 3.04m

Assets

This companyUSD 138.16kMedianUSD 119.88kAverageUSD 3.90m

News

2026-10-06

Excelya at COG CRO Summit Europe 2026: Key Clinical Operations Insights

Exploring sponsor and CRO partnerships, site engagement, quality oversight, AI and practical approaches to strengthening clinical trial delivery.

2026-09-28

Excelya at Patient Safety Congress 2026 in Amsterdam

Explore Excelya’s insights from World Patient Safety Congress Europe 2026 in Amsterdam on AI, compliance and PV outsourcing.

Industry

Offer

Clinical trials
Pharmacovigilance
Clinical data management
Clinical trial documentation management
Medical affairs
Statistical analysis
Regulatory affairs

Certifications: ECOVADIS, ISO 9001

Website technology

Website

WordPress

Analytics and marketing

Google Tag Manager

Authorized Representatives

François Moisson – President of the Management Board

Konstantinos Kantzos – Management Board Member

Manner of representation

Each member of the management board acting independently is entitled to represent the company.

Ownership

Owner	Shares	Share value	Stake
Zein Biotec Limited	99	$1,337.12	99%
Others	1	$13.51	1%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2022-06-02.

Bank Millennium
47 1160 2202 0000 0005 3043 4855
Bank Millennium
53 1160 2202 0000 0005 3043 5038

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Clinbitsp. z o.o.	$114,041.47	clinbit.com
Opessp. z o.o.	$56,182.11	opes.com.pl
Medapp Clinical Researchsp. z o.o.	$55,499.75	medappclinicalresearch.pl
Biostat Research and Developmentsp. z o.o.	$50,225.77	biostat.com.pl
Biomedical Centerssp. z o.o.	$41,376.85	biomedical-centers.com
Edoktor24 Servicessp. z o.o.	$34,089.64	edoktor24.pl
Neuro-Opiomelsp. z o.o.	$19,173.50	neuroopiomel.com
Acta Medicasp. z o.o.	$16,968.27	actamedica.pl
Scilosp. z o.o.	$12,634.81	scilo.eu
Oncotherics PolandS.A.	$7,565.33	oncotherics.com

FAQ

Last updated: 2026-07-20